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Highlights 
 A literature search demonstrated the widespread use of isolate-level measurement 
of resistance 
 Faecal samples were tested for antimicrobial resistant E. coli at both the sample-
level and the isolate-level 
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 Sample-level measurement was more likely to demonstrate resistance 
 Using simulation we back predict isolate-level results from an historic study that 
only used sample-level measurement 
 We question the widespread use of single isolate tests as demonstrated by our 
literature search 
 
 
Introduction 
The primary problem associated with antimicrobial resistance (AMR) is failure of 
treatment in human medicine. However, resistance does not, generally, originate de 
novo in the patient in which treatment fails; rather it exists in a number of reservoirs 
within the patient's environment (Woolhouse et al., 2015). Treatment of the patient 
with an antimicrobial agent then provides a strong selection pressure in which resistant 
populations can outcompete their non-resistant counterparts. In order to address the 
interdependence of levels of AMR between a number of potential sources, a “systems 
map” approach has been suggested (Department of Health, 2014). The “systems maps” 
proposed are complex, pictorial representations of the inter-connections between 
reservoirs of potential resistance, possible transmission of resistance, and points of 
amplification of resistance in the presence of antimicrobials. Ideally we would identify 
which parts of the map were most amenable to modification and which parts are best 
targeted to address the main problem, which is resistance in human medicine. To do this 
requires accurate measurement of the component parts of the map. One key 
measurement is the prevalence of resistance in different bacterial reservoirs that make 
up the system of AMR and its transfer. 
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Prevalence estimates depend upon a sampling unit being defined as positive or 
negative. The number of bacteria in each sampling unit may be very large (e.g. >109  per 
gram of faeces) and, in faeces for example, can vary by several orders of magnitude 
(Smith and Crabb, 1961). Therefore it is not obvious how many bacteria per sample 
should be tested nor the threshold for the number of “positive” (i.e. resistant) bacteria 
that should deem a sample as being resistant. Alternatively there are various methods 
that seek to test the sample as a whole such as spread plating [e.g. “culturing” on agar 
(Batura et al., 2010)], streak plating in which samples are serially diluted on the agar 
through streaking to enable picking of isolates (Amyes et al., 1992; Gunn et al., 2008; 
Humphry and Gunn, 2014), and detection of genetic markers of resistance via methods 
such as PCR or sequencing (Waldeisen et al., 2011). It is not clear to us why only one 
bacterium per sample should be tested to determine a sample as resistant or sensitive. 
Comparisons between different methods on single isolates exist (Benedict et al., 2013; 
Dorado-Garcia et al., 2016; Lo-Ten-Foe et al., 2007; Luangtongkum et al., 2007; Luber et 
al., 2003) but we are not aware of anything that has been published comparing isolate 
based methods with whole sample methods. In this paper we quantify the relationship 
between streak plating and isolate-based methods of measuring resistance by applying 
both types of method to the same samples. Then, using historic baseline prevalence 
data for samples based on a sample-level test (streak-plating), we used the quantified 
relationship to back-calibrate and estimate the consequences had our baseline study 
used an isolate-based approach. This provides a “proof of concept” of how data such as 
these can be used to compare prevalence estimates across different studies that use 
different measures of resistance. Overall we seek to highlight that there is a need for the 
scientific community to reconsider the validity of taking a single bacterium per sample. 
Abstract 
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Antimicrobial resistance is primarily a problem in human medicine but there are 
unquantified links of transmission in both directions between animal and human 
populations. Quantitative assessment of the costs and benefits of reduced antimicrobial 
usage in livestock requires robust quantification of transmission of resistance between 
animals, the environment and the human population. This in turn requires appropriate 
measurement of resistance. To tackle this we selected two different methods for 
determining whether a sample is resistant – one based on screening a sample, the other 
on testing individual isolates. Our overall objective was to explore the differences arising 
from choice of measurement. A literature search demonstrated the widespread use of 
testing of individual isolates. 
Keywords: antimicrobial resistance; AMR; antibiotic; measurement; prevalence 
The first aim of this study was to compare, quantitatively, sample level and isolate level 
screening. Cattle or sheep faecal samples (n=41) submitted for routine parasitology 
were tested for antimicrobial resistance in two ways: (1) “streak” direct culture onto 
plates containing the antimicrobial of interest; (2) determination of minimum inhibitory 
concentration (MIC) of 8-10 isolates per sample compared to published MIC thresholds. 
Two antibiotics (ampicillin and nalidixic acid) were tested.  With ampicillin, direct culture 
resulted in more than double the number of resistant samples than the MIC method 
based on eight individual isolates. 
The second aim of this study was to demonstrate the utility of the observed relationship 
between these two measures of antimicrobial resistance to re-estimate the prevalence 
of antimicrobial resistance from a previous study, in which we had used “streak” 
cultures.  Boot-strap methods were used to estimate the proportion of samples that 
would have tested resistant in the historic study, had we used the isolate-based MIC 
method instead.  Our boot-strap results indicate that our estimates of prevalence of 
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antimicrobial resistance would have been considerably lower in the historic study had 
the MIC method been used.  
Finally we conclude that there is no single way of defining a sample as resistant to an 
antimicrobial agent. The method used greatly affects the estimated prevalence of 
antimicrobial resistance in a sampled population of animals, thus potentially resulting in 
misleading results. Comparing methods on the same samples allows us to re-estimate 
the prevalence from other studies, had other methods for determining resistance been 
used. The results of this study highlight the importance of establishing what the most 
appropriate measure of antimicrobial resistance is, for the proposed purpose of the 
results. 
Materials and Methods 
Literature survey 
To provide evidence regarding the use of individual isolates in relevant published studies 
we carried out a literature search. The search terms “prevalence antimicrobial resistance 
livestock” were entered into the online literature database “Web of Science”. The search 
hits were ordered in decreasing “relevance” to the search terms and the 50 most 
relevant hits were then sought through the SRUC online access system. Any papers that 
were accessible were then read to determine whether the microbiological test was a 
sample based method (such as streak plating or spread plating) or a method based on 
isolates and, if so, how many isolates per sample. 
Comparative study sampling 
Sub-samples were taken from 41 faecal samples submitted for routine parasitological 
(i.e. non-bacterial) screening from cattle (25 samples) and sheep (16 samples) to the SAC 
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(Scottish Agricultural College) Veterinary Investigation Centre, Inverness between 
August 2013 and July 2014. This study we call the “comparative study”.  
Comparative study laboratory methods 
Each sample was ‘streak’ cultured on three plates: a standard MacConkey plate and two 
containing antibiotic (ampicillin 16mg/L or nalidixic acid 15 mg/L). The streaking process 
on the plates involved sequentially streaking sub-samples from one streak to the next 
with the result that the concentration of sample decreased with each consecutive streak 
on a plate.  
Where present, one putative E. coli colony from each of the two antibiotic-containing 
plates was randomly selected resulting in 0-2 “resistant” isolates. From the standard 
(non-antibiotic) plate 8-10 colonies were selected in addition to the “resistant” isolates 
to make up a total of ten isolates selected per sample in order to make full use of the 
ten wells per row on the test plates.  These ten morphologically typical lactose 
fermenting colonies were selected and identified as E. coli based on their reactions in 
oxidase, indole, urease and Simmon’s citrate tests (Cowan, et al., 1993). They were then 
tested for the Minimum Inhibitory Concentration (MIC) for ampicillin, and nalidixic acid 
using concentrations from an appropriate standard with priority given to EUCAST 
(“European Committee on Antimicrobial Susceptibility Testing”) (see Table 1) 
breakpoints, or, if these were unavailable (in the case of nalidixic acid) then we used 
BSAC (British Society for Antimicrobial Chemotherapy) breakpoints. 
We have not assumed any level of sensitivity or specificity for either of the tests used. 
This is because it is not clear that there is a gold standard. Instead we calculate the 
conditional probabilities of each test dependent on the result of the other.  
Comparative Data Analysis 
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Only samples from which eight or more validated E. coli isolates were identified from 
the control plate, and tested for MIC were included in the analysis. Where a sample 
resulted in more than eight isolates being tested (maximum of ten) a sub-sample of 
eight was randomly selected from these data in order to achieve statistical balance. 
Hereafter these data will be referred to as the comparative study data. 
 
Statistical tests within the comparative study 
A McNemar exact test (package exact2x2 in R, (Fay, 2010)) was used to test whether the 
apparent difference in “marginal proportions” (i.e. prevalence using each method) was 
statistically significant.  
The conditional probabilities and confidence intervals were calculated assuming a 
binomial process using exact binomial confidence limits (using binom.test in R), relating 
the probability of a sample testing resistant or sensitive using one test conditional on 
the result from the other test.  
 
Assessing clustering (over-dispersion) 
The assessment of statistical clustering (aka “over-dispersion”) of resistant isolates was 
carried out with a quasi-binomial model in comparison to a null model of a binomial 
distribution based on a single overall proportion of isolates resistant. 
We defined each isolate as resistant or sensitive according to the relevant EUCAST or 
BSAC definition. Results were aggregated at the sample level and a binomial logistic 
model was run. This was re-run as a quasi-binomial model (which allows for clustering) 
and a chi-squared test used to test the significance of the dispersion accounted for in 
the quasi-binomial model (Dobson, 2002). This procedure was used on all samples for 
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both the ampicillin and nalidixic results and on the subset of samples for which streak 
plating tested resistance in the case of ampicillin. The number of samples testing 
resistant to nalidixic acid by streak plating was too few to allow the procedure to be run 
on just these samples. 
 
Historic sample-level prevalence study used for an illustration of re-calibration 
Historic sample-level data, based on plate streaking as described previously (Gunn et al., 
2008; Humphry and Gunn, 2014), were used to provide an illustration of the consequence 
of different definitions of a resistant sample. From a randomised survey of healthy animals, 
faeces samples were taken (1086 lambs from 104 randomly selected sheep farms, 312 
calves aged less than 6 weeks, and 804 adult cattle were collected from 100 randomly 
selected farms throughout the Highlands and Islands of Scotland). Faecal samples were 
tested using streak plating (see above) on three plates in total, one without antibiotic (i.e. 
control) and two with either of the respective two antibiotics (ampicillin & nalidixic acid). A 
sample was defined as being resistant if any isolates which grew on an antibiotic-containing 
plate were demonstrated to be E. coli. Hereafter these data will be referred to as the 
baseline study data. 
 
Simulated re-estimation 
A bootstrap approach was used to obtain 95% percentiles for the re-calibrated 
estimated animal level prevalence from the baseline study data of healthy animals. This 
was done for both antibiotics: ampicillin and nalidixic acid. By bootstrapping from the 
comparative study data we allow for clustering for which there was evidence in the 
comparative study data (see Results). 
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For each resistant sample (one sample per animal) in our baseline study (streak plate), a 
randomly selected resistant streak-plate sample from our comparative study was 
selected. The predicted results from testing a single isolate, and eight isolates were 
simulated by randomly sampling with replacement from the corresponding data from 
the comparative study. If one or more of the isolates in each of these random selections 
were resistant isolates, then the baseline sample was deemed to be simulated as 
“EUCAST1sim” or “EUCAST8sim” resistant for the one and eight isolate sampling 
respectively. Then, using these predicted results for resistance, we calculated the 
population prevalence simulated as if a single isolate, or eight isolates had been tested 
using the EUCAST/BSAC criteria. This process was repeated 1000 times to provide a 95% 
percentile interval for the original baseline study prevalence based on bootstrapping 
from the comparative study.   
The prevalence that we report for the baseline study and the simulated re-estimation is 
the proportion of samples positive with one sample per animal in the baseline study. 
This boot-strapping method is illustrated in Figure 1 in the form of a flow diagram. 
 
Results 
Literature sample 
From the fifty most “relevant” (according to the search engine in Web of Science) papers 
returned, we were able, through the SRUC online library system to access 18 papers for 
examination (see appendix for full list of these papers). Of the 18 papers we accessed, 
eight did not state the number of isolates tested per sample, four papers were not 
applicable (e.g. review papers), five specifically stated that they tested one isolate per 
sample, and one paper declared that they tested “up to two colonies per plate”. 
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Comparative study 
In total, 41 samples were tested. An insufficient number of confirmed E. coli isolates 
were obtained from one sample to be included in the data analysis. Of the remaining 40 
samples: three showed resistance by streak plating to nalidixic acid; fourteen showed 
resistance by streak plating to ampicillin. The 40 samples all yielded eight or more 
isolates from the control plate for further testing.  
Table 2 gives cross-classification of samples measured as resistant or not according to 
the streak plate method and according to the testing of eight isolates for their MIC 
(EUCAST/BSAC method). One or more isolates from one of these samples is interpreted 
here as defining the sample as resistant using EUCAST/BSAC thresholds.  Using the exact 
McNemar test we found that the difference in “marginal proportions” (i.e. prevalence 
using each method) was statistically significant at the 5% level in the case of ampicillin 
(p=0.008) but not for nalidixic acid (p=0.5). 
 
Note that no isolates were classified as resistant using the EUCAST method from 
samples that were classified as sensitive using the streak plate method. 
Table 3 provides estimates and confidence intervals for the conditional probability of a 
result dependent on a result using the alternative method. The confidence intervals are 
relatively wide due to the relatively small sample size. It is noticeable that the estimates 
for the conditional probabilities for ampicillin and nalidixic acid are close to one another. 
Whilst taking into account the large confidence intervals, it is noteworthy that there is a 
large overlap of confidence ranges -except in the case of Pr(sample tests sensitive with 
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streak plating given that the sample contributed 0 resistant isolates from eight) in which 
the overlap is smaller.  
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*From the six samples that contributed at least one ampicillin resistant isolate there 
were, in total, 18 resistant isolates and thirty sensitive isolates. From the one sample 
that contributed at least one nalidixic resistant isolate there were six resistant and two 
sensitive isolates.  
Evidence of clustering 
Evidence of clustering is presented visually (Figure 2) as well as analysed statistically. The 
histogram of the actual data has “fatter tails” than the expected number (the points) 
suggesting clustering in the data. 
 
 
In the case of nalidixic acid only three samples tested resistant using the streak plating, 
of these three samples, two had no isolates testing resistant and the third sample had 
six out of the eight isolates testing resistant. The proportion of isolates resistant from 
samples testing resistant (to nalidixic acid using streak plating) is therefore 6/24 = 0.25 
(0.10, 0.47). The probability of a single sample (testing resistant using streak plating) 
giving six or more isolates resistant if we assume a background isolate level prevalence 
of 0.25 amongst those samples testing resistant using streak plating, may be calculated 
from the cumulative distribution function of the binomial and is p=0.004 for a single, 
specified sample and p=0.012 for any one of three samples. Therefore despite the low 
numbers of resistant samples, this low p-value suggests clustering may also be present 
for nalidixic acid.  
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More formal statistical testing for clustering was also employed. In the case of ampicillin 
the procedure could be run on all samples and also on only those samples that tested 
resistant using streak plating. In the case of nalidixic acid the number of samples that 
tested resistant using streak plating was low and therefore the statistical procedure was 
only appropriate when applied to all samples. In the case of ampicillin the p-values 
(1.3*10-20 including all samples and 2*10-7 for just those samples which tested resistant 
using streak plating) strongly suggest clustering. Similarly for nalidixic acid, a p-value of 
1.8*10-30 strongly suggests clustering when all samples were included. We therefore 
chose to use the bootstrap approach for back calculation rather than rely on a binomial 
assumption for the distribution of positive isolates. 
Phenotypic diversity 
Figure 3 illustrates the distribution of MIC values from samples broken down by the 
status of each sample according to the streak-plating sample-level method. Note that 
samples that tested resistant by streak-plating contained isolates from both sides of the 
breakpoint.  
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Simulated re-estimation 
The simulated estimates for the prevalences based on one or eight isolates from a 
control plate (EUCAST1sim and EUCAST8sim) are substantially lower than the original 
streak plating estimates collected in the baseline prevalence survey (Tables 4, 5). 
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Discussion 
Our literature search demonstrated that studies reporting prevalence of antimicrobial 
resistance commonly estimate the resistance using just one isolate per sample. The 
justification for this choice of measurement over alternatives, for example the whole 
sample streak plating method, does not appear to be considered. Results presented in 
this paper demonstrate that the method used affects the prevalence estimate greatly. 
The data presented allowed us to relate, quantitatively, one method (isolate-based) with 
another (streak plating). Other studies have looked at the relationship between different 
methods based on testing the same isolates (Benedict et al., 2013; Dorado-Garcia et al., 
2016; Lo-Ten-Foe et al., 2007; Luangtongkum et al., 2007; Luber et al., 2003) but work 
comparing sample based testing with isolate based testing has not been reported to the 
authors’ knowledge. We report here such a comparison. This comparison is based on a 
small sample size but never the less gives interesting results for quantifying the 
relationship between the two different methods of testing for antimicrobial resistance. 
We see from the 2 by 2 classification tables (Results) that when compared to a sample of 
eight isolates tested for MIC and classified under EUCAST or BSAC guidelines, the streak 
plating method appears more likely to categorise a sample as resistant. This is either 
because the method is more sensitive or less specific (or a combination of both) than 
the measured MIC-based isolate method for both ampicillin and nalidixic acid. 
Our thesis is that there is no single gold standard for defining a sample as resistant or 
sensitive. It may be tempting however to assume 100% specificity, that is, when 
resistance is identified by any method, then it is assumed that the sample contains 
phenotypically resistant bacteria of the species of interest. For the purposes of this 
study we do not need to make this assumption and therefore we do not do so. In short 
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we have not chosen either method, or a combination of the two, as being a gold 
standard test. 
The distribution of MIC values (Figure 3) for isolates taken from samples deemed 
sensitive and resistant using the streak plate method suggest a bimodal distribution 
(Martinez, 2014) for both ampicillin and nalidixic acid. Since these appear to cluster on 
either side of the MIC threshold for defining resistance, this suggests that the cut-off 
used has relevance to the bacterial population. It is clear that streak plate sensitive 
samples only provided sensitive isolates whilst the streak plate resistant samples 
included isolates from both resistant and sensitive sub-populations. For both ampicillin 
and nalidixic acid, the majority of isolates from samples found to be resistant using 
streak plating were themselves found to be sensitive using the measured MIC and the 
relevant MIC threshold. This is further evidence of phenotypic diversity amongst isolates 
within a single sample deemed resistant by streak plating (Humphry et al., 2002).  
We found strong evidence of clustering. This evidence means that resistant E. coli are 
not homogenously or randomly dispersed amongst samples. If clustering were 100% 
complete then a sample would be either all resistant or all sensitive. Such a situation 
would mean that taking a single isolate per sample would be sufficient to describe the 
sample. In practice, the data show that there is good evidence of a mixture of resistant 
and sensitive isolates within a resistant sample even with the clustering observed. 
Antimicrobial resistance is a complex system. There are different species of bacteria 
within a sample, and different antimicrobials to consider. Even when we restrict our 
view to a single bacterial species and a single antimicrobial, different clones (colony 
forming units) within a sample will demonstrate the ability to grow in different 
concentrations of antimicrobial (MIC). Alternatively, given what we know of the ability 
of resistant genes to cross species boundaries within intestinal systems (horizontal 
AC
CE
PT
ED
 M
AN
US
CR
IPT
17   
 
transfer) (Huddleston, 2014), we might believe that we need to consider the presence of 
resistance genes throughout the whole bacterial population. The description of a sample 
as “susceptible” or “resistant” therefore represents a single binary summary of the 
whole bacterial population, its sampling and testing processes. We could think of this 
population summary as being analogous to providing a summary statistic from a sample. 
We do not believe that the summary statistic fully describes the population, but it may 
be useful as an indication of one aspect of the population's distribution. 
We know that the density of bacteria in faeces can be very high and can vary from 
animal to animal by orders of magnitude (Smith and Crabb, 1961) and we know that the 
isolate-level prevalence within a sample of E. coli that are resistant can vary greatly 
(Humphry et al., 2002). Therefore even when we test as many as eight isolates we 
identify fewer samples as being resistant compared to when we test using the streak 
plating method. It is valuable to demonstrate this empirically and to give quantitative 
estimates to the relationship between methods. The streak plating method is inherently 
capable of screening a very large, but not quantified, number of isolates at one time. We 
also note that it is common for studies of prevalence of resistance to test one isolate per 
sample (see appendix) and this is likely to affect resistance prevalence estimates to a 
greater extent than in the case of eight isolates per sample (Table 2). This suggests that 
streak plating would be more sensitive or less specific than testing one or eight isolates 
per sample - with the caveat that there is no gold standard. 
To show one potential use of our results, we back-calculated our prevalence estimate 
from a randomly sampled baseline historic study had we used one or eight isolates 
determined resistant or susceptible using a breakpoint defined method (Table 2). This 
back-calibration is only applicable if we assume that the relationship between the two 
tests was the same in the population considered by the historic baseline study as it was 
AC
CE
PT
ED
 M
AN
US
CR
IPT
18   
 
in our more recent comparative study. The most important assumption is that the 
frequency distribution of number of resistant isolates within a sample that tests 
resistant using streak plating has stayed approximately the same. The similarity in the 
conditional probabilities (Table 3) between ampicillin and nalidixic acid indicate that for 
faecal samples, the statistical relationship between streak plating results and isolate 
based results may be fairly consistent across populations. The wide confidence intervals 
around these conditional probabilities is a consequence of the low numbers of samples 
in our study. In the absence of any knowledge to the contrary, assuming that 
relationship to be the same is the most parsimonious position to start - until evidence is 
found to the contrary. Again, our back-calibrated estimates for prevalence of resistance, 
using one or eight isolates, are substantially lower than those originally reported, based 
upon the streak plating method. Our primary conclusion is that the prevalence estimates 
that researchers produce are a function of the laboratory method of summarising the 
multitude of latent “data” that are the population of bacteria of interest in a sample.  
Given how much the results we present depend on the method used, it is our belief that 
the scientific community, even at this stage, ought to be open-minded to using the best 
available method to answer a particular question. For example, highly sensitive methods 
such as streak plating, spread plating or genetic screening for resistance genes through 
PCR or whole gene sequencing might become more relevant as we attempt to 
understand the antibiotic resistance “systems map” better (Department of Health, 
2014). There are environments (such as livestock holdings or hospitals) in which 
antibiotic use, through natural selection pressure, might quickly and substantially 
amplify even very low levels of resistance. Therefore using a measure that is effective at 
identifying resistance even when present in low levels, may be a better predictor of 
future clinical problems or transfer of resistance than a method which focusses on a 
small number of isolates.  
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There is another important potential advantage of systems of measurement that screen 
samples of bacteria rather than only testing individual picked isolates. Screening 
samples inherently takes into account, without necessarily measuring directly, the 
bacterial density of the sample (Humphry and Gunn, 2014). When modelling risk of 
transfer of bacteria from one environment to another, the bacterial density is an 
important contributor to the risk (Gerhardts et al., 2012). Streak plating, plate screening 
and sample screening for genetic markers of resistance fulfil this function of inherently 
accounting for bacterial density within their system of measurement. Methods such as 
streak plating do not however, by themselves, offer estimates of bacterial density, but 
they are positively correlated with bacterial density (Humphry and Gunn, 2014). 
In conclusion, we hope we have presented sufficient evidence to support our thesis that 
the prevalence estimate of antibiotic resistance is greatly dependent on the method 
used. The extent of this we believe may surprise many. Sample level methods, not based 
on individual isolates, but screening the sample as a whole can be much more sensitive 
at identifying low within-sample prevalences of resistance. We present the argument 
that sample level screening techniques in the future should be an important part of the 
research community’s armoury when trying to populate systems level models such as 
the “systems map” (Department of Health, 2014). Understanding which screening 
measure is best for particular clinical or research questions should therefore be one 
component of the widespread and escalating research effort demanded by society.  
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for useful criticism of the manuscript 
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Figure 1. A flow diagram illustrating the algorithm for simulating results from the 
baseline data as if the samples had been tested using the isolate based method. 
 
Figure 2. Histogram for the frequency of samples based on the number of resistant 
isolates (out of eight tested from each sample) from those samples that tested resistant 
to ampicillin using streak plating. The black dots give the expected number of samples if 
the process were a purely binomial process with a single isolate-level prevalence for all 
samples that tested resistant using streak plating.  
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Figure 3. Frequency of MICs to ampicillin or nalidixic acid for each of the eight E. coli 
isolates from each of the forty samples in the comparative study. Light bars indicate 
isolates taken from samples that tested sensitive to antibiotic when tested using the 
streak plating method. Dark grey indicates isolates taken from samples that tested 
resistant to antibiotic when tested using the streak plating method. The EUCAST 
guidelines state that a threshold MIC of over eight mg/L should be deemed resistant.  
For nalidixic acid the BSAC guidelines state that a threshold MIC of over 16 mg/L should 
be deemed resistant. The results for ampicillin are in the top graph, results for nalidixic 
acid are in the bottom graph. 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
31   
 
 
 
Table 1: The two antibiotics, the concentrations (µg/mL) used in the agar plates for 
testing the sample using the plate streak method and the MIC breakpoints chosen to 
determine an isolate’s categorisation as sensitive/resistant. 
Units in µg/mL Ampicillin Nalidixic acid 
Concentration used in streak plate 16 15 
Sensitive threshold for isolate MIC MIC a ≤ 8 MICb ≤16 
a. EUCAST, 2015;  
b. BSAC, 2012;  
 
 
Appendix I 
Eighteen references accessed online under the search terms: “prevalence antimicrobial 
resistance livestock” within the Web of Knowledge database: 
 
Reference Description of sampling method 
Clinical sample or 
not clinical sample 
(Argudín and Butayea, 2016) implied one isolate per sample but not explicit Not clinical 
(Alonso et al., 2016) 
"Up to 2 colonies per plate were selected for 
posterior identification Not clinical 
(Katakweba et al., 2016) Number of isolates per sample not stated Not clinical 
(Horigan et al., 2016) Review  
(Hanon et al., 2015) "one isolate/faecal sample" Not clinical 
(Van Boeckel et al., 2015) Review of usage  
(Guerra et al., 2014) Number of isolates per sample not stated Not clinical 
(Schwaiger et al., 2014) Number of isolates per sample not stated Not clinical 
(Burow et al., 2014) 
Review - unstated number of isolates per 
sample 
Treatment and 
control groups 
(Roug et al., 2013) Number of isolates per sample not stated Not clinical 
(Thai et al., 2012) Number of isolates per sample not stated Not clinical 
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(Kreausukon et al., 2012) Number of isolates per sample not stated Not clinical 
(Egger et al., 2012) Number of isolates per sample not stated Not clinical 
(Hur et al., 2012) Review  
(Williams et al., 2011) Faecal broth sample Not clinical 
(Guenther et al., 2010a) One colony per sample Not clinical 
(Guenther et al., 2010b) One colony per sample Not clinical 
(Padungtod and Kaneene, 
2006) 
One isolate per sample went through to AST 
testing Some clinical 
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Table 2. A cross classification of resistance to ampicillin and nalidixic acid for samples 
tested using the measured EUCAST or BSAC isolate MIC based method and the sample 
level streak plating method from samples taken in the calibration study.  
  
 
 Streak plating method 
 
   Sensitive Resistant 
MIC method. 
Sample resistant 
if at least one out 
of eight isolates 
resistant. 
Ampicillin Sensitive 26 8  
 Resistant 0 6*  
    
Nalidixic acid Sensitive 37 2 
 Resistant 0 1* 
 
Table 3. The conditional probabilities and confidence intervals (calculated assuming a 
binomial process using binom.test() in R) relating the probability of a sample testing 
resistant or sensitive using one test depending on the result from the other test. The 
symbol “|” is the statistical symbol for the conditional “given that”. 
 Ampicillin Nalidixic acid 
Pr(resistant isolates >0 | sample tested 
resistant with streak plating) 
0.43 (0.18, 0.71) 0.33 (0.008, 0.91) 
Pr(resistant isolates >0 | sample tested 
sensitive with streak plating) 
0 (0.00, 0.13) 0 (0.00, 0.09) 
Pr(a single isolate is resistant | sample tested 
resistant with streak plating) 
0.16 (0.10, 0.24) 0.25 (0.10, 0.47) 
Pr(a single isolate is resistant | sample tested 
sensitive with streak plating) 
0 (0.00, 0.13) 0 (0.00, 0.09) 
AC
CE
PT
ED
 M
AN
US
CR
IPT
36   
 
Pr(sample tests sensitive with streak plating | 
sample contributed 0 resistant isolates from 
eight) 
0.76 (0.59, 0.89) 0.95 (0.83, 0.99) 
Pr(sample tests resistant with streak plating | 
sample contributed >0 resistant isolates from 
eight) 
1.00 (0.54, 1.00) 1.00 (0.025, 1.00) 
 
Table 4. The predicted base-line animal-level prevalences for resistance to ampicillin, 
simulated and based on either single or eight isolates.  Prevalence predictions presented 
with their percentile intervals in comparison to the prevalence estimated originally using 
streak plating. 
 
 
 
Animal-level (i.e. sample-level) prevalence estimate of ampicillin 
resistance 
 Streak plate 
animal-level 
prevalence 
from original 
baseline 
survey 
Simulated median 
and 95% percentile 
interval for animal-
level prevalence 
had one isolate 
been tested  
(EUCAST1sim) 
Simulated median 
and 95% percentile 
interval for animal-
level prevalence 
had eight isolates 
been tested 
(EUCAST8sim) 
Calves 88% 14% (11%, 18%) 31% (25%, 36%) 
Adult 
Cattle 
47% 7.6% (6.0%, 9.5%) 17% (14%, 19%) 
Sheep 19% 3.1% (2.2%, 4.1%) 6.7% (5.5%, 7.9%) 
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Table 5. The predicted base-line animal-level prevalences for resistance to nalidixic acid, 
simulated and based on either single or eight isolates.  Prevalence predictions presented 
with their percentile intervals in comparison to the prevalence estimated originally using 
streak plating. 
 
 
Animal-level (i.e. sample-level) prevalence estimate of nalidixic acid resistance 
 Streak plate 
animal-level 
prevalence from 
original baseline 
survey 
Simulated median and 
95% percentile interval 
for animal-level 
prevalence had one 
isolate been tested 
(EUCAST1sim) 
Simulated median 
and 95% percentile 
interval for animal-
level prevalence had 
eight isolates been 
tested 
(EUCAST8sim) 
Calves 6.69% 1.59% (0.64%, 2.87%) 2.23% (0.96%, 3.50%) 
Adult 
Cattle 
1.84% 0.49% (0.12%, 0.86%)  0.61% (0.12%, 1.10%) 
Sheep 0.64% 0.16% (0%, 0.40%) 0.16% (0%, 0.40%) 
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